Autor: "Durant JF" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Optimized DNA-based identification of Toxocara spp. eggs in soil and sand samples.
Autorzy:: Jarosz W; Department of Biology and Anatomy, Faculty of Health Sciences, Poznań University of Physical Education, Królowej Jadwigi 27/39, 61-871, Poznan, Poland.
Durant JF; Center for Applied Molecular Technologies, Institute of Clinical and Experimental Research, Université Catholique de Louvain, Tour Claude Bernard, Avenue Hippocrate 54-55, 1st Floor, B1.54.01, 1200, Brussels, Belgium.
Irenge LMWB; Center for Applied Molecular Technologies, Institute of Clinical and Experimental Research, Université Catholique de Louvain, Tour Claude Bernard, Avenue Hippocrate 54-55, 1st Floor, B1.54.01, 1200, Brussels, Belgium.; Defense Laboratories Department, ACOS Ops & Trg, Belgian Armed Forces, Martelarenstraat, 181, 1800, Peutie, Belgium.
Fogt-Wyrwas R; Department of Biology and Anatomy, Faculty of Health Sciences, Poznań University of Physical Education, Królowej Jadwigi 27/39, 61-871, Poznan, Poland.
Mizgajska-Wiktor H; Department of Biology and Anatomy, Faculty of Health Sciences, Poznań University of Physical Education, Królowej Jadwigi 27/39, 61-871, Poznan, Poland.
Gala JL; Center for Applied Molecular Technologies, Institute of Clinical and Experimental Research, Université Catholique de Louvain, Tour Claude Bernard, Avenue Hippocrate 54-55, 1st Floor, B1.54.01, 1200, Brussels, Belgium. .; Pokaż więcej
Źródło:: Parasites & vectors [Parasit Vectors] 2021 Aug 26; Vol. 14 (1), pp. 426. Date of Electronic Publication: 2021 Aug 26.
Typ publikacji:: Journal Article
MeSH Terms:: Ovum*
DNA, Helminth/*genetics
Parasite Egg Count/*methods
Sand/*parasitology
Soil/*parasitology
Toxocara canis/*genetics
Animals ; Real-Time Polymerase Chain Reaction ; Species Specificity

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Genomic analysis of pathogenic isolates of Vibrio cholerae from eastern Democratic Republic of the Congo (2014-2017).
Autorzy:: Irenge LM; Center for Applied Molecular Technologies, Institute of Clinical and Experimental Research, Université catholique de Louvain, Brussels, Belgium.; Defence Laboratories Department, ACOS Ops&Trg, Belgian Armed Forces, Peutie, Belgium.
Ambroise J; Center for Applied Molecular Technologies, Institute of Clinical and Experimental Research, Université catholique de Louvain, Brussels, Belgium.
Mitangala PN; Laboratoire Provincial du Nord-Kivu, Goma, Democratic Republic of the Congo.
Bearzatto B; Center for Applied Molecular Technologies, Institute of Clinical and Experimental Research, Université catholique de Louvain, Brussels, Belgium.
Kabangwa RKS; AMI-LABO, Goma, North-Kivu province, Democratic Republic of the Congo.
Durant JF; Center for Applied Molecular Technologies, Institute of Clinical and Experimental Research, Université catholique de Louvain, Brussels, Belgium.
Gala JL; Center for Applied Molecular Technologies, Institute of Clinical and Experimental Research, Université catholique de Louvain, Brussels, Belgium.; Pokaż więcej
Źródło:: PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2020 Apr 20; Vol. 14 (4), pp. e0007642. Date of Electronic Publication: 2020 Apr 20 (Print Publication: 2020).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Genotype*
Cholera/*microbiology
Vibrio cholerae/*classification
Vibrio cholerae/*genetics
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Child ; Child, Preschool ; Cholera/epidemiology ; Cluster Analysis ; DNA, Bacterial/genetics ; Democratic Republic of the Congo/epidemiology ; Female ; Humans ; Infant ; Male ; Middle Aged ; Molecular Epidemiology ; Phylogeny ; Prophages/genetics ; Vibrio cholerae/isolation & purification ; Whole Genome Sequencing ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Backward compatibility of whole genome sequencing data with MLVA typing using a new MLVAtype shiny application for Vibrio cholerae.
Autorzy:: Ambroise J; Center for Applied Molecular Technologies, Institute of Clinical and Experimental Research, Université catholique de Louvain, Brussels, Belgium.
Irenge LM; Center for Applied Molecular Technologies, Institute of Clinical and Experimental Research, Université catholique de Louvain, Brussels, Belgium.
Durant JF; Center for Applied Molecular Technologies, Institute of Clinical and Experimental Research, Université catholique de Louvain, Brussels, Belgium.
Bearzatto B; Center for Applied Molecular Technologies, Institute of Clinical and Experimental Research, Université catholique de Louvain, Brussels, Belgium.
Bwire G; Ministry of Health Uganda, Department of Community Health, Kampala, Uganda.
Stine OC; University of Maryland School of Medicine, Department of Epidemiology and Public Health, Baltimore, Maryland, United States of America.
Gala JL; Center for Applied Molecular Technologies, Institute of Clinical and Experimental Research, Université catholique de Louvain, Brussels, Belgium.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2019 Dec 11; Vol. 14 (12), pp. e0225848. Date of Electronic Publication: 2019 Dec 11 (Print Publication: 2019).
Typ publikacji:: Journal Article
MeSH Terms:: Whole Genome Sequencing*
Minisatellite Repeats/*genetics
Vibrio cholerae O1/*genetics
Algorithms ; Genetic Loci ; Genome, Bacterial ; Uganda

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Whole-genome sequences of multidrug-resistant Escherichia coli in South-Kivu Province, Democratic Republic of Congo: characterization of phylogenomic changes, virulence and resistance genes.
Autorzy:: Irenge LM; Center for Applied Molecular Technologies, Institute of Clinical and Experimental Research, Université catholique de Louvain, Clos chapelle-aux-champs, 30 B1.30.24, 1200, Brussels, Belgium.; Defence Laboratories Department, ACOS Ops&Trg, Belgian Armed Forces, Martelarenstraat, 181, 1800, Peutie, Belgium.
Ambroise J; Center for Applied Molecular Technologies, Institute of Clinical and Experimental Research, Université catholique de Louvain, Clos chapelle-aux-champs, 30 B1.30.24, 1200, Brussels, Belgium.
Bearzatto B; Center for Applied Molecular Technologies, Institute of Clinical and Experimental Research, Université catholique de Louvain, Clos chapelle-aux-champs, 30 B1.30.24, 1200, Brussels, Belgium.
Durant JF; Center for Applied Molecular Technologies, Institute of Clinical and Experimental Research, Université catholique de Louvain, Clos chapelle-aux-champs, 30 B1.30.24, 1200, Brussels, Belgium.
Chirimwami RB; Université Catholique de Bukavu, P.O. Box 285, Bukavu, Democratic Republic of Congo.
Gala JL; Center for Applied Molecular Technologies, Institute of Clinical and Experimental Research, Université catholique de Louvain, Clos chapelle-aux-champs, 30 B1.30.24, 1200, Brussels, Belgium. .; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2019 Feb 11; Vol. 19 (1), pp. 137. Date of Electronic Publication: 2019 Feb 11.
Typ publikacji:: Journal Article
MeSH Terms:: Whole Genome Sequencing*
Drug Resistance, Multiple, Bacterial/*genetics
Escherichia coli Infections/*microbiology
Extraintestinal Pathogenic Escherichia coli/*genetics
Anti-Bacterial Agents/pharmacology ; Democratic Republic of the Congo ; Escherichia coli Infections/epidemiology ; Extraintestinal Pathogenic Escherichia coli/drug effects ; Extraintestinal Pathogenic Escherichia coli/enzymology ; Genotype ; Humans ; Multilocus Sequence Typing ; Phylogeny ; Plasmids ; Virulence/genetics ; Virulence Factors/genetics ; beta-Lactamases/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Correction: Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea.
Autorzy:: Sissoko D
Laouenan C
Folkesson E
M'Lebing AB
Beavogui AH
Baize S
Camara AM
Maes P
Shepherd S
Danel C
Carazo S
Conde MN
Gala JL
Colin G
Savini H
Bore JA
Le Marcis F
Koundouno FR
Petitjean F
Lamah MC
Diederich S
Tounkara A
Poelart G
Berbain E
Dindart JM
Duraffour S
Lefevre A
Leno T
Peyrouset O
Irenge L
Bangoura N
Palich R
Hinzmann J
Kraus A
Barry TS
Berette S
Bongono A
Camara MS
Munoz VC
Doumbouya L
Harouna S
Kighoma PM
Koundouno FR
Lolamou R
Loua CM
Massala V
Moumouni K
Provost C
Samake N
Sekou C
Soumah A
Arnould I
Komano MS
Gustin L
Berutto C
Camara D
Camara FS
Colpaert J
Delamou L
Jansson L
Kourouma E
Loua M
Malme K
Manfrin E
Maomou A
Milinouno A
Ombelet S
Sidiboun AY
Verreckt I
Yombouno P
Bocquin A
Carbonnelle C
Carmoi T
Frange P
Mely S
Nguyen VK
Pannetier D
Taburet AM
Treluyer JM
Kolie J
Moh R
Gonzalez MC
Kuisma E
Liedigk B
Ngabo D
Rudolf M
Thom R
Kerber R
Gabriel M
Di Caro A
Wölfel R
Badir J
Bentahir M
Deccache Y
Dumont C
Durant JF
El Bakkouri K
Uwamahoro MG
Smits B
Toufik N
Van Cauwenberghe S
Ezzedine K
D'Ortenzio E
Pizarro L
Etienne A
Guedj J
Fizet A
de Sainte Fare EB
Murgue B
Tran-Minh T
Rapp C
Piguet P
Poncin M
Draguez B
Duverger TA
Barbe S
Baret G
Defourny I
Carroll M
Raoul H
Augier A
Eholie SP
Yazdanpanah Y
Levy-Marchal C
Antierrens A
Van Herp M
Günther S
de Lamballerie X
Keïta S
Mentre F
Anglaret X
Malvy D; Pokaż więcej
Corporate Authors:: JIKI Study Group
Źródło:: PLoS medicine [PLoS Med] 2016 Apr 05; Vol. 13 (4), pp. e1002009. Date of Electronic Publication: 2016 Apr 05 (Print Publication: 2016).
Typ publikacji:: Published Erratum

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea.
Autorzy:: Sissoko D; Inserm, UMR 1219, Université de Bordeaux, Bordeaux, France.; Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.
Laouenan C; Inserm, IAME, UMR 1137, Université Paris Diderot, Paris, France.; Assistance Publique-Hôpitaux de Paris, Hôpital Bichat Claude Bernard, Paris, France.
Folkesson E; Médecins Sans Frontières Belgique, Brussels, Belgium.
M'Lebing AB; ALIMA, Dakar, Senegal.
Beavogui AH; Centre de Recherche en Santé Rurale, Maférinya, Guinea.
Baize S; Institut Pasteur, Centre International de Recherche en Infectiologie, Lyon, France.; Inserm, Laboratoire P4 Jean Mérieux, Lyon, France.
Camara AM; Médecins Sans Frontières Belgique, Brussels, Belgium.
Maes P; European Mobile Laboratory Project, Hamburg, Germany.; Rega Institute for Medical Research, Leuven, Belgium.
Shepherd S; ALIMA, Dakar, Senegal.
Danel C; Inserm, UMR 1219, Université de Bordeaux, Bordeaux, France.; ALIMA, Dakar, Senegal.; Programme PACCI, Abidjan, Côte d'Ivoire.
Carazo S; Médecins Sans Frontières Belgique, Brussels, Belgium.
Conde MN; ALIMA, Dakar, Senegal.
Gala JL; Biological Light Fieldable Laboratory for Emergencies (B-LiFE)/Belgian First Aid and Support (B-FAST), Brussels, Belgium.; Cliniques Universitaires Saint-Luc, Brussels, Belgium.; Université Catholique de Louvain, Louvain-la-Neuve, Belgium.; Belgian Ministry of Defense, Brussels, Belgium.
Colin G; Inserm, UMR 1219, Université de Bordeaux, Bordeaux, France.; Programme PACCI, Abidjan, Côte d'Ivoire.; Croix Rouge Française, Paris, France.
Savini H; Service de Santé des Armées, Paris, France.
Bore JA; European Mobile Laboratory Project, Hamburg, Germany.; Institut National de Santé Publique, Conakry, Guinea.; Laboratoire des Fièvres Hémorragiques en Guinée, Université Gamal Abdel Nasser de Conakry, Conakry, Guinea.
Le Marcis F; Ecole Normale Supérieure, Lyon, France.
Koundouno FR; European Mobile Laboratory Project, Hamburg, Germany.; Institut National de Santé Publique, Conakry, Guinea.; Laboratoire des Fièvres Hémorragiques en Guinée, Université Gamal Abdel Nasser de Conakry, Conakry, Guinea.
Petitjean F; ALIMA, Dakar, Senegal.
Lamah MC; Médecins Sans Frontières Belgique, Brussels, Belgium.
Diederich S; European Mobile Laboratory Project, Hamburg, Germany.; Friedrich Loeffler Institute-Federal Research Institute for Animal Health, Greifswald, Germany.
Tounkara A; Médecins Sans Frontières Belgique, Brussels, Belgium.
Poelart G; Médecins Sans Frontières Belgique, Brussels, Belgium.
Berbain E; Médecins Sans Frontières Belgique, Brussels, Belgium.
Dindart JM; ALIMA, Dakar, Senegal.
Duraffour S; European Mobile Laboratory Project, Hamburg, Germany.; Rega Institute for Medical Research, Leuven, Belgium.
Lefevre A; Médecins Sans Frontières Belgique, Brussels, Belgium.
Leno T; Médecins Sans Frontières Belgique, Brussels, Belgium.
Peyrouset O; ALIMA, Dakar, Senegal.
Irenge L; Biological Light Fieldable Laboratory for Emergencies (B-LiFE)/Belgian First Aid and Support (B-FAST), Brussels, Belgium.; Belgian Ministry of Defense, Brussels, Belgium.
Bangoura N; Médecins Sans Frontières Belgique, Brussels, Belgium.
Palich R; ALIMA, Dakar, Senegal.
Hinzmann J; European Mobile Laboratory Project, Hamburg, Germany.; Robert Koch Institute, Berlin, Germany.
Kraus A; European Mobile Laboratory Project, Hamburg, Germany.; Public Health Agency of Sweden, Solna, Sweden.
Barry TS; ALIMA, Dakar, Senegal.
Berette S; ALIMA, Dakar, Senegal.
Bongono A; ALIMA, Dakar, Senegal.
Camara MS; ALIMA, Dakar, Senegal.
Chanfreau Munoz V; ALIMA, Dakar, Senegal.
Doumbouya L; ALIMA, Dakar, Senegal.
Souley Harouna; ALIMA, Dakar, Senegal.
Kighoma PM; ALIMA, Dakar, Senegal.
Koundouno FR; ALIMA, Dakar, Senegal.
Réné Lolamou; ALIMA, Dakar, Senegal.
Loua CM; ALIMA, Dakar, Senegal.
Massala V; ALIMA, Dakar, Senegal.
Moumouni K; ALIMA, Dakar, Senegal.
Provost C; ALIMA, Dakar, Senegal.
Samake N; ALIMA, Dakar, Senegal.
Sekou C; ALIMA, Dakar, Senegal.
Soumah A; ALIMA, Dakar, Senegal.
Arnould I; Médecins Sans Frontières Belgique, Brussels, Belgium.
Komano MS; Médecins Sans Frontières Belgique, Brussels, Belgium.
Gustin L; Médecins Sans Frontières Belgique, Brussels, Belgium.
Berutto C; Médecins Sans Frontières Belgique, Brussels, Belgium.
Camara D; Médecins Sans Frontières Belgique, Brussels, Belgium.
Camara FS; Médecins Sans Frontières Belgique, Brussels, Belgium.
Colpaert J; Médecins Sans Frontières Belgique, Brussels, Belgium.
Delamou L; Médecins Sans Frontières Belgique, Brussels, Belgium.
Jansson L; Médecins Sans Frontières Belgique, Brussels, Belgium.
Kourouma E; Médecins Sans Frontières Belgique, Brussels, Belgium.
Loua M; Médecins Sans Frontières Belgique, Brussels, Belgium.
Malme K; Médecins Sans Frontières Belgique, Brussels, Belgium.
Manfrin E; Médecins Sans Frontières Belgique, Brussels, Belgium.
Maomou A; Médecins Sans Frontières Belgique, Brussels, Belgium.
Milinouno A; Médecins Sans Frontières Belgique, Brussels, Belgium.
Ombelet S; Médecins Sans Frontières Belgique, Brussels, Belgium.
Sidiboun AY; Médecins Sans Frontières Belgique, Brussels, Belgium.
Verreckt I; Médecins Sans Frontières Belgique, Brussels, Belgium.
Yombouno P; Médecins Sans Frontières Belgique, Brussels, Belgium.
Bocquin A; Inserm, Laboratoire P4 Jean Mérieux, Lyon, France.
Carbonnelle C; Inserm, Laboratoire P4 Jean Mérieux, Lyon, France.
Carmoi T; Service de Santé des Armées, Paris, France.
Frange P; Assistance Publique-Hôpitaux de Paris, Hôpital Necker-Enfants Malades, Paris, France.
Mely S; Inserm, Laboratoire P4 Jean Mérieux, Lyon, France.
Nguyen VK; Université de Montréal, Montréal, Canada.
Pannetier D; Inserm, Laboratoire P4 Jean Mérieux, Lyon, France.
Taburet AM; Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Paris, France.
Treluyer JM; Assistance Publique-Hôpitaux de Paris, Hôpital Necker-Enfants Malades, Paris, France.
Kolie J; Centre de Recherche en Santé Rurale, Maférinya, Guinea.
Moh R; Inserm, UMR 1219, Université de Bordeaux, Bordeaux, France.; Programme PACCI, Abidjan, Côte d'Ivoire.
Gonzalez MC; Inserm, IAME, UMR 1137, Université Paris Diderot, Paris, France.; Assistance Publique-Hôpitaux de Paris, Hôpital Bichat Claude Bernard, Paris, France.
Kuisma E; European Mobile Laboratory Project, Hamburg, Germany.; Public Health England, Porton Down, United Kingdom.
Liedigk B; European Mobile Laboratory Project, Hamburg, Germany.; Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
Ngabo D; European Mobile Laboratory Project, Hamburg, Germany.; Public Health England, Porton Down, United Kingdom.
Rudolf M; European Mobile Laboratory Project, Hamburg, Germany.; Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
Thom R; European Mobile Laboratory Project, Hamburg, Germany.; Public Health England, Porton Down, United Kingdom.
Kerber R; European Mobile Laboratory Project, Hamburg, Germany.; Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
Gabriel M; European Mobile Laboratory Project, Hamburg, Germany.; Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
Di Caro A; European Mobile Laboratory Project, Hamburg, Germany.; National Institute for Infectious Diseases 'L. Spallanzani,' Rome, Italy.
Wölfel R; European Mobile Laboratory Project, Hamburg, Germany.; Bundeswehr Institute of Microbiology, Munich, Germany.
Badir J; Biological Light Fieldable Laboratory for Emergencies (B-LiFE)/Belgian First Aid and Support (B-FAST), Brussels, Belgium.; Cliniques Universitaires Saint-Luc, Brussels, Belgium.
Bentahir M; Biological Light Fieldable Laboratory for Emergencies (B-LiFE)/Belgian First Aid and Support (B-FAST), Brussels, Belgium.; Belgian Ministry of Defense, Brussels, Belgium.
Deccache Y; Biological Light Fieldable Laboratory for Emergencies (B-LiFE)/Belgian First Aid and Support (B-FAST), Brussels, Belgium.; Belgian Ministry of Defense, Brussels, Belgium.
Dumont C; Biological Light Fieldable Laboratory for Emergencies (B-LiFE)/Belgian First Aid and Support (B-FAST), Brussels, Belgium.; Belgian Ministry of Defense, Brussels, Belgium.
Durant JF; Biological Light Fieldable Laboratory for Emergencies (B-LiFE)/Belgian First Aid and Support (B-FAST), Brussels, Belgium.; Université Catholique de Louvain, Louvain-la-Neuve, Belgium.
El Bakkouri K; Biological Light Fieldable Laboratory for Emergencies (B-LiFE)/Belgian First Aid and Support (B-FAST), Brussels, Belgium.; Université Catholique de Louvain, Louvain-la-Neuve, Belgium.
Gasasira Uwamahoro M; Biological Light Fieldable Laboratory for Emergencies (B-LiFE)/Belgian First Aid and Support (B-FAST), Brussels, Belgium.; Université Catholique de Louvain, Louvain-la-Neuve, Belgium.
Smits B; Biological Light Fieldable Laboratory for Emergencies (B-LiFE)/Belgian First Aid and Support (B-FAST), Brussels, Belgium.; Université Catholique de Louvain, Louvain-la-Neuve, Belgium.
Toufik N; Biological Light Fieldable Laboratory for Emergencies (B-LiFE)/Belgian First Aid and Support (B-FAST), Brussels, Belgium.; Cliniques Universitaires Saint-Luc, Brussels, Belgium.
Van Cauwenberghe S; Biological Light Fieldable Laboratory for Emergencies (B-LiFE)/Belgian First Aid and Support (B-FAST), Brussels, Belgium.; Belgian Ministry of Defense, Brussels, Belgium.
Ezzedine K; Inserm, UMR 1219, Université de Bordeaux, Bordeaux, France.
D'Ortenzio E
Pizarro L; Solidarité Thérapeutique et Initiatives pour la Santé (Solthis), Paris, France.
Etienne A; Inserm, IAME, UMR 1137, Université Paris Diderot, Paris, France.; Assistance Publique-Hôpitaux de Paris, Hôpital Bichat Claude Bernard, Paris, France.
Guedj J; Inserm, IAME, UMR 1137, Université Paris Diderot, Paris, France.; Assistance Publique-Hôpitaux de Paris, Hôpital Bichat Claude Bernard, Paris, France.
Fizet A; Institut Pasteur, Centre International de Recherche en Infectiologie, Lyon, France.; Inserm, Laboratoire P4 Jean Mérieux, Lyon, France.
Barte de Sainte Fare E; ALIMA, Dakar, Senegal.
Murgue B; Inserm, Paris, France.
Tran-Minh T; Croix Rouge Française, Paris, France.
Rapp C; Service de Santé des Armées, Paris, France.
Piguet P; Médecins Sans Frontières Belgique, Brussels, Belgium.
Poncin M; Médecins Sans Frontières Belgique, Brussels, Belgium.
Draguez B; Médecins Sans Frontières Belgique, Brussels, Belgium.
Allaford Duverger T; ALIMA, Dakar, Senegal.
Barbe S; ALIMA, Dakar, Senegal.
Baret G; ALIMA, Dakar, Senegal.
Defourny I; ALIMA, Dakar, Senegal.
Carroll M; European Mobile Laboratory Project, Hamburg, Germany.; Public Health England, Porton Down, United Kingdom.; Southampton General Hospital, University of Southampton, Southampton, United Kingdom.
Raoul H; Inserm, Laboratoire P4 Jean Mérieux, Lyon, France.
Augier A; ALIMA, Dakar, Senegal.
Eholie SP; Inserm, UMR 1219, Université de Bordeaux, Bordeaux, France.; Programme PACCI, Abidjan, Côte d'Ivoire.; Centre Hospitalier Universitaire de Treichville, Abidjan, Côte d'Ivoire.
Yazdanpanah Y; Assistance Publique-Hôpitaux de Paris, Hôpital Bichat Claude Bernard, Paris, France.
Levy-Marchal C; Inserm, Paris, France.
Antierrens A; Médecins Sans Frontières Belgique, Brussels, Belgium.
Van Herp M; Médecins Sans Frontières Belgique, Brussels, Belgium.
Günther S; European Mobile Laboratory Project, Hamburg, Germany.; Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
de Lamballerie X; Université Aix Marseille, Institut de Recherche pour le Développement, École des Hautes Études en Santé Publique, EPV, Marseille, France.
Keïta S; Cellule de Coordination Nationale de Lutte contre la Maladie à Virus Ebola, Conakry, Guinea.
Mentre F; Inserm, IAME, UMR 1137, Université Paris Diderot, Paris, France.; Assistance Publique-Hôpitaux de Paris, Hôpital Bichat Claude Bernard, Paris, France.
Anglaret X; Inserm, UMR 1219, Université de Bordeaux, Bordeaux, France.; Programme PACCI, Abidjan, Côte d'Ivoire.
Malvy D; Inserm, UMR 1219, Université de Bordeaux, Bordeaux, France.; Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.; Pokaż więcej
Corporate Authors:: JIKI Study Group
Źródło:: PLoS medicine [PLoS Med] 2016 Mar 01; Vol. 13 (3), pp. e1001967. Date of Electronic Publication: 2016 Mar 01 (Print Publication: 2016).
Typ publikacji:: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Amides/*therapeutic use
Antiviral Agents/*therapeutic use
Hemorrhagic Fever, Ebola/*drug therapy
Pyrazines/*therapeutic use
Adolescent ; Adult ; Child ; Child, Preschool ; Ebolavirus/genetics ; Feasibility Studies ; Female ; Guinea ; Hemorrhagic Fever, Ebola/diagnosis ; Historically Controlled Study ; Humans ; Infant ; Male ; RNA, Viral/blood ; Reverse Transcriptase Polymerase Chain Reaction ; Therapies, Investigational ; Treatment Outcome ; Viral Load ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Unambiguous detection of multiple TP53 gene mutations in AAN-associated urothelial cancer in Belgium using laser capture microdissection.
Autorzy:: Aydin S; Department of Pathology, Cliniques Universitaires Saint-Luc (CUSL), Université Catholique de Louvain (UCL), Institut de Recherche Expérimentale et Clinique (IREC), Brussels, Belgium.
Dekairelle AF; Center for Applied Molecular Technologies (CTMA), Cliniques Universitaires Saint-Luc (CUSL), Université Catholique de Louvain (UCL), Institut de Recherche Expérimentale et Clinique (IREC), Brussels, Belgium.
Ambroise J; Center for Applied Molecular Technologies (CTMA), Cliniques Universitaires Saint-Luc (CUSL), Université Catholique de Louvain (UCL), Institut de Recherche Expérimentale et Clinique (IREC), Brussels, Belgium.
Durant JF; Center for Applied Molecular Technologies (CTMA), Cliniques Universitaires Saint-Luc (CUSL), Université Catholique de Louvain (UCL), Institut de Recherche Expérimentale et Clinique (IREC), Brussels, Belgium.
Heusterspreute M; Center for Applied Molecular Technologies (CTMA), Cliniques Universitaires Saint-Luc (CUSL), Université Catholique de Louvain (UCL), Institut de Recherche Expérimentale et Clinique (IREC), Brussels, Belgium.
Guiot Y; Department of Pathology, Cliniques Universitaires Saint-Luc (CUSL), Université Catholique de Louvain (UCL), Institut de Recherche Expérimentale et Clinique (IREC), Brussels, Belgium.
Cosyns JP
Gala JL; Center for Applied Molecular Technologies (CTMA), Cliniques Universitaires Saint-Luc (CUSL), Université Catholique de Louvain (UCL), Institut de Recherche Expérimentale et Clinique (IREC), Brussels, Belgium.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2014 Sep 03; Vol. 9 (9), pp. e106301. Date of Electronic Publication: 2014 Sep 03 (Print Publication: 2014).
Typ publikacji:: Journal Article
MeSH Terms:: Aristolochic Acids/*adverse effects
Tumor Suppressor Protein p53/*genetics
Urologic Neoplasms/*genetics
Adult ; Belgium ; Female ; Humans ; Laser Capture Microdissection ; Middle Aged ; Point Mutation ; Taiwan ; Urologic Neoplasms/chemically induced ; Urologic Neoplasms/pathology

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Duplex quantitative real-time PCR assay for the detection and discrimination of the eggs of Toxocara canis and Toxocara cati (Nematoda, Ascaridoidea) in soil and fecal samples.
Autorzy:: Durant JF; Centre de Technologies Moléculaires Appliquées, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Clos Chapelle-aux-Champs, 30 B1.30.24, 1200 Brussels, Belgium.
Irenge LM
Fogt-Wyrwas R
Dumont C
Doucet JP
Mignon B
Losson B
Gala JL; Pokaż więcej
Źródło:: Parasites & vectors [Parasit Vectors] 2012 Dec 07; Vol. 5, pp. 288. Date of Electronic Publication: 2012 Dec 07.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Feces/*parasitology
Ovum/*classification
Real-Time Polymerase Chain Reaction/*veterinary
Soil/*parasitology
Toxocara/*classification
Animals ; DNA, Helminth/genetics ; DNA, Ribosomal Spacer/genetics ; RNA, Helminth/genetics ; Real-Time Polymerase Chain Reaction/methods ; Sensitivity and Specificity ; Species Specificity ; Toxocariasis/diagnosis ; Toxocariasis/parasitology